Edition:
United Kingdom

Ascendis Pharma A/S (ASND.OQ)

ASND.OQ on NASDAQ Stock Exchange Global Select Market

124.16USD
20 May 2019
Change (% chg)

-- (--)
Prev Close
$124.16
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
94,446
52-wk High
$131.69
52-wk Low
$53.29

About

Ascendis Pharma A/S is a clinical-stage biopharmaceutical company. The Company is engaged in applying its TransCon technology to develop sustained release prodrug therapies with several product candidates in clinical and preclinical development. The Company is developing its product candidate, TransCon human growth hormone... (more)

Overall

Beta: 0.86
Market Cap(Mil.): $5,748.87
Shares Outstanding(Mil.): 46.30
Dividend: --
Yield (%): --

Financials

  ASND.OQ Industry Sector
P/E (TTM): -- 97.03 55.51
EPS (TTM): -3.56 -- --
ROI: -55.68 7.44 11.59
ROE: -55.68 7.90 16.33

Earnings vs. Estimates